PHENTERMINE HYDROCHLORIDE; TOPIRAMATE | A208175 | DR REDDYS LABORATORIES SA
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
VIVUS, INC. v. DR. REDDY'S LABORATORIES, S.A. et al 8 patentsANDA 208175phentermine and topiramate extended-release | D.N.J. | 2015-04-15 | Terminated 2017-09-06 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$3.41
per ea
Lowest NADAC/Unit
$3.03
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 43598062730PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE | $3.41 | EA | Generic | — | 2026-06-17 |
| 43598062530PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE | $3.37 | EA | Generic | — | 2026-06-17 |
| 43598062430PHENTERMINE-TOPIRAMATE ER 3.75-23 MG CAPSULE | $3.30 | EA | Generic | — | 2026-06-17 |
| 43598062630PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE | $3.03 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.